Kalm Therapeutics, Inc. is a pre-clinical drug development company founded in 2024 and focused on pioneering a breakthrough treatment for eczema.
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see KALM Therapeutics, Inc. →Already a subscriber? Sign in
Xcout Intel tracks KALM Therapeutics, Inc. continuously — this profile deepens as new filings, funding, people and hiring data arrive.